{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:58:40Z","timestamp":1760061520848,"version":"3.37.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00101-009-1626-9","type":"journal-article","created":{"date-parts":[[2009,11,4]],"date-time":"2009-11-04T19:28:23Z","timestamp":1257362903000},"page":"1136-1143","source":"Crossref","is-referenced-by-count":5,"title":["Antiinflammatorische Effekte von Pentoxifyllin","Anti-inflammatory effects of pentoxifylline"],"prefix":"10.1007","volume":"58","author":[{"given":"H.V.","family":"Groesdonk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Heringlake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Heinze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,11,6]]},"reference":[{"key":"1626_CR1","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","volume":"119","author":"Akriviadis","year":"2000","unstructured":"Akriviadis E, Botla R, Briggs W et al (2000) Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 119:1637\u20131648","journal-title":"Gastroenterology"},{"key":"1626_CR2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0022-2828(80)90023-1","volume":"12","author":"Argel","year":"1980","unstructured":"Argel MI, Vittone L, Grassi AO et al (1980) Effect of phosphodiesterase inhibitors on heart contractile behaviour, protein kinase activity and cyclic nucleotide levels. J Mol Cell Cardiol 12:939\u2013954","journal-title":"J Mol Cell Cardiol"},{"key":"1626_CR3","doi-asserted-by":"crossref","unstructured":"Asimakopoulos G, Gourlay T (2003) A review of anti-inflammatory strategies in cardiac surgery. Perfusion 18 [Suppl 1]:7\u201312","DOI":"10.1191\/0267659103pf623oa"},{"key":"1626_CR4","first-page":"255","volume":"47","author":"Bahlmann","year":"2006","unstructured":"Bahlmann L, Weber C, Heinrichs G et al (2006) The effect of pentoxifylline on cognitive dysfunction and mood state after open coronary revascularisation while using the heart-lung machine. Anaesthesiol Intensivmed 47:255\u2013263","journal-title":"Anaesthesiol Intensivmed"},{"key":"1626_CR5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3233\/BIR-1990-273-417","volume":"27","author":"Barroso-Aranda","year":"1990","unstructured":"Barroso-Aranda J, Schmid-Schonbein GW (1990) Pentoxifylline pretreatment decreases the pool of circulating activated neutrophils, in-vivo adhesion to endothelium, and improves survival from hemorrhagic shock. Biorheology 27:401\u2013418","journal-title":"Biorheology"},{"key":"1626_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/clpt.1985.6","volume":"37","author":"Beermann","year":"1985","unstructured":"Beermann B, Ings R, Mansby J et al (1985) Kinetics of intravenous and oral pentoxifylline in healthy subjects. Clin Pharmacol Ther 37:25\u201328","journal-title":"Clin Pharmacol Ther"},{"key":"1626_CR7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/jlb.40.6.747","volume":"40","author":"Bessler","year":"1986","unstructured":"Bessler H, Gilgal R, Djaldetti M et al (1986) Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells. J Leukoc Biol 40:747\u2013754","journal-title":"J Leukoc Biol"},{"key":"1626_CR8","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0003-4975(01)02462-6","volume":"71","author":"Boldt","year":"2001","unstructured":"Boldt J, Brosch C, Lehmann A et al (2001) Prophylactic use of pentoxifylline on inflammation in elderly cardiac surgery patients. Ann Thorac Surg 71:1524\u20131529","journal-title":"Ann Thorac Surg"},{"key":"1626_CR9","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/00003246-200105000-00008","volume":"29","author":"Boldt","year":"2001","unstructured":"Boldt J, Brosch C, Piper SN et al (2001) Influence of prophylactic use of pentoxifylline on postoperative organ function in elderly cardiac surgery patients. Crit Care Med 29:952\u2013958","journal-title":"Crit Care Med"},{"key":"1626_CR10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1191\/0267659105pf779oa","volume":"20","author":"Cagli","year":"2005","unstructured":"Cagli K, Ulas MM, Ozisik K et al (2005) The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass. Perfusion 20:45\u201351","journal-title":"Perfusion"},{"key":"1626_CR11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/jsre.1996.4940","volume":"67","author":"Coe","year":"1997","unstructured":"Coe DA, Freischlag JA, Johnson D et al (1997) Pentoxifylline prevents endothelial damage due to ischemia and reperfusion injury. J Surg Res 67:21\u201325","journal-title":"J Surg Res"},{"key":"1626_CR12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.ta.0000200075.12489.74","volume":"60","author":"Coimbra","year":"2006","unstructured":"Coimbra R, Melbostad H, Loomis W et al (2006) LPS-induced acute lung injury is attenuated by phosphodiesterase inhibition: effects on proinflammatory mediators, metalloproteinases, NF-kappaB, and ICAM-1 expression. J Trauma 60:115\u2013125","journal-title":"J Trauma"},{"key":"1626_CR13","first-page":"575","volume":"59","author":"Coimbra","year":"2005","unstructured":"Coimbra R, Melbostad H, Loomis W et al (2005) Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia. J Trauma 59:575\u2013582","journal-title":"J Trauma"},{"key":"1626_CR14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/sur.2005.6.73","volume":"6","author":"Coimbra","year":"2005","unstructured":"Coimbra R, Porcides RD, Melbostad H et al (2005) Nonspecific phosphodiesterase inhibition attenuates liver injury in acute endotoxemia. Surg Infect 6:73\u201385","journal-title":"Surg Infect"},{"key":"1626_CR15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MPA.0b013e3181612d19","volume":"37","author":"De","year":"2008","unstructured":"De Campos T, Deree J, Martins JO et al (2008) Pentoxifylline attenuates pulmonary inflammation and neutrophil activation in experimental acute pancreatitis. Pancreas 37:42\u201349","journal-title":"Pancreas"},{"key":"1626_CR16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2004-815798","volume":"52","author":"Ege","year":"2004","unstructured":"Ege T, Arar C, Canbaz S et al (2004) The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery. Thorac Cardiovasc Surg 52:10\u201315","journal-title":"Thorac Cardiovasc Surg"},{"key":"1626_CR17","first-page":"S97","volume":"6","author":"Faist","year":"1998","unstructured":"Faist E, Kim C (1998) Therapeutic immunomodulatory approaches for the control of systemic inflammatory response syndrome and the prevention of sepsis. New Horiz 6:S97\u2013S102","journal-title":"New Horiz"},{"key":"1626_CR18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/000155501317208408","volume":"81","author":"Friedrich","year":"2001","unstructured":"Friedrich M, Sterry W, Klein A et al (2001) Addition of pentoxifylline could reduce the side effects of fumaric acid esters in the treatment of psoriasis. Acta Derm Venereol 81:429\u2013430","journal-title":"Acta Derm Venereol"},{"key":"1626_CR19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2143\/AC.61.1.2005134","volume":"61","author":"Golbasi","year":"2006","unstructured":"Golbasi I, Akbas H, Ozdem S et al (2006) The effect of pentoxifylline on haemolysis during cardiopulmonary bypass in open-heart surgery. Acta Cardiol 61:7\u201311","journal-title":"Acta Cardiol"},{"key":"1626_CR20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000209378","volume":"32","author":"Groesdonk","year":"2009","unstructured":"Groesdonk HV, Bauer A, Kreft B et al (2009) Urodilatin and pentoxifylline prevent the early onset of Escherichia coli-induced acute renal failure in a model of isolated perfused rat kidney. Kidney Blood Press Res 32:81\u201390","journal-title":"Kidney Blood Press Res"},{"key":"1626_CR21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejcts.2007.04.011","volume":"32","author":"Heinze","year":"2007","unstructured":"Heinze H, Rosemann C, Weber C et al (2007) A single prophylactic dose of pentoxifylline reduces high dependency unit time in cardiac surgery \u2013 a prospective randomized and controlled study. Eur J Cardiothorac Surg 32:83\u201389","journal-title":"Eur J Cardiothorac Surg"},{"key":"1626_CR22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4269\/ajtmh.1997.56.397","volume":"56","author":"Hemmer","year":"1997","unstructured":"Hemmer CJ, Hort G, Chiwakata CB et al (1997) Supportive pentoxifylline in falciparum malaria: no effect on tumor necrosis factor alpha levels or clinical outcome: a prospective, randomized, placebo-controlled study. Am J Trop Med Hyg 56:397\u2013403","journal-title":"Am J Trop Med Hyg"},{"key":"1626_CR23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00024382-199804000-00001","volume":"9","author":"Hoffmann","year":"1998","unstructured":"Hoffmann H, Markewitz A, Kreuzer E et al (1998) Pentoxifylline decreases the incidence of multiple organ failure in patients after major cardio-thoracic surgery. Shock 9:235\u2013240","journal-title":"Shock"},{"key":"1626_CR24","doi-asserted-by":"crossref","first-page":"E100","DOI":"10.1532\/HSF98.20081153","volume":"12","author":"Iskesen","year":"2009","unstructured":"Iskesen I, Kurdal AT, Kahraman N et al (2009) Preoperative oral pentoxifylline for management of cytokine reactions in cardiac surgery. Heart Surg Forum 12:E100\u2013E104","journal-title":"Heart Surg Forum"},{"key":"1626_CR25","doi-asserted-by":"crossref","first-page":"E883","DOI":"10.1532\/HSF98.20061090","volume":"9","author":"Iskesen","year":"2006","unstructured":"Iskesen I, Saribulbul O, Cerrahoglu M et al (2006) Pentoxifylline affects cytokine reaction in cardiopulmonary bypass. Heart Surg Forum 9:E883\u2013E887","journal-title":"Heart Surg Forum"},{"key":"1626_CR26","first-page":"102","volume":"22","author":"Kleinschmidt","year":"1997","unstructured":"Kleinschmidt S, Bauer M, Grundmann U et al (1997) Effect of gamma-hydroxybutyric acid and pentoxifylline on kidney function parameters in coronary surgery interventions. Anaesthesiol Reanim 22:102\u2013107","journal-title":"Anaesthesiol Reanim"},{"key":"1626_CR27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/14017438409102392","volume":"18","author":"Koul","year":"1984","unstructured":"Koul BL, Nordhas O, Sonnenfeld T et al (1984) The effect of pentoxifylline on impaired red cell deformability following open-heart surgery. Scand J Thorac Cardiovasc Surg 18:129\u2013131","journal-title":"Scand J Thorac Cardiovasc Surg"},{"key":"1626_CR28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1472-8206.1999.tb00345.x","volume":"13","author":"Kowalski","year":"1999","unstructured":"Kowalski J, Kosmider M, Pasnik J et al (1999) Pentoxifylline decreases neutrophil respiratory bursts in patients with stable angina. Fundam Clin Pharmacol 13:237\u2013242","journal-title":"Fundam Clin Pharmacol"},{"key":"1626_CR29","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00003246-199904000-00042","volume":"27","author":"Lauterbach","year":"1999","unstructured":"Lauterbach R, Pawlik D, Kowalczyk D et al (1999) Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial. Crit Care Med 27:807\u2013814","journal-title":"Crit Care Med"},{"key":"1626_CR30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/BF01955273","volume":"155","author":"Lauterbach","year":"1996","unstructured":"Lauterbach R, Zembala M (1996) Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis. Eur J Pediatr 155:404\u2013409","journal-title":"Eur J Pediatr"},{"key":"1626_CR31","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1097\/00003246-199909000-00027","volume":"27","author":"McKinley","year":"1999","unstructured":"McKinley BA, Butler BD (1999) Comparison of skeletal muscle PO2, PCO2, and pH with gastric tonometric P(CO2) and pH in hemorrhagic shock. Crit Care Med 27:1869\u20131877","journal-title":"Crit Care Med"},{"key":"1626_CR32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1399-0012.1997.tb00800.x","volume":"11","author":"Noel","year":"1997","unstructured":"Noel C, Hazzan M, Coppin MC et al (1997) A randomized controlled trial of pentoxifylline for the prevention of delayed graft function in cadaveric kidney graft. Clin Transplant 11:169\u2013173","journal-title":"Clin Transplant"},{"key":"1626_CR33","first-page":"69","volume":"62","author":"Otani","year":"2008","unstructured":"Otani S, Kuinose M, Murakami T et al (2008) Preoperative oral administration of pentoxifylline ameliorates respiratory index after cardiopulmonary bypass through decreased production of IL-6. Acta Med Okayama 62:69\u201374","journal-title":"Acta Med Okayama"},{"key":"1626_CR34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/sj.bjp.0706871","volume":"149","author":"Pereda","year":"2006","unstructured":"Pereda J, Gomez-Cambronero L, Alberola A et al (2006) Co-administration of pentoxifylline and thiopental causes death by acute pulmonary oedema in rats. Br J Pharmacol 149:450\u2013455","journal-title":"Br J Pharmacol"},{"key":"1626_CR35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-5728(95)00176-X","volume":"64","author":"Rieckmann","year":"1996","unstructured":"Rieckmann P, Weber F, Gunther A et al (1996) Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis. J Neuroimmunol 64:193\u2013200","journal-title":"J Neuroimmunol"},{"key":"1626_CR36","first-page":"153","volume":"15","author":"Sakaguchi","year":"1978","unstructured":"Sakaguchi T, Hayashi S (1978) Pentoxifylline: pharmacology and clinical trials of pentoxifylline. Pharmacometrics 15:153\u2013183","journal-title":"Pharmacometrics"},{"key":"1626_CR37","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-2249.1998.00510.x","volume":"111","author":"Sampaio","year":"1998","unstructured":"Sampaio EP, Moraes MO, Nery JA et al (1998) Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL). Clin Exp Immunol 111:300\u2013308","journal-title":"Clin Exp Immunol"},{"key":"1626_CR38","first-page":"223","volume":"301","author":"Schade","year":"1989","unstructured":"Schade UF, Von Der Bosch J, Schonharting M (1989) Pentoxifylline increases survival of mice in endotoxic shock. Prog Clin Biol Res 301:223\u2013227","journal-title":"Prog Clin Biol Res"},{"key":"1626_CR39","first-page":"195","volume":"15","author":"Schreiber","year":"1983","unstructured":"Schreiber P, Schr\u00f6ppel M, Heidrich H (1983) Effects of naftidrofuryl, pentoxifylline and bencyclane on the renal blood flow and renal excretion of conscious dogs. Herz 15:195\u2013201","journal-title":"Herz"},{"key":"1626_CR40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurjhf\/hfn040","volume":"11","author":"Shaw","year":"2009","unstructured":"Shaw SM, Shah MK, Williams SG et al (2009) Immunological mechanisms of pentoxifylline in chronic heart failure. Eur J Heart Fail 11:113\u2013118","journal-title":"Eur J Heart Fail"},{"key":"1626_CR41","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00003246-199803000-00021","volume":"26","author":"Silomon","year":"1998","unstructured":"Silomon M, Pizanis A, Larsen R et al (1998) Pentoxifylline prevention of altered hepatocyte calcium regulation during hemorrhagic shock\/resuscitation. Crit Care Med 26:494\u2013500","journal-title":"Crit Care Med"},{"key":"1626_CR42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1388-9842(02)00008-9","volume":"4","author":"Sliwa","year":"2002","unstructured":"Sliwa K, Skudicky D, Candy G et al (2002) The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail 4:305\u2013309","journal-title":"Eur J Heart Fail"},{"key":"1626_CR43","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0002-9149(02)02779-0","volume":"90","author":"Sliwa","year":"2002","unstructured":"Sliwa K, Woodiwiss A, Candy G et al (2002) Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 90:1118\u20131122","journal-title":"Am J Cardiol"},{"key":"1626_CR44","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/01.CIR.0000112568.48837.60","volume":"109","author":"Sliwa","year":"2004","unstructured":"Sliwa K, Woodiwiss A, Kone VN et al (2004) Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study. Circulation 109:750\u2013755","journal-title":"Circulation"},{"key":"1626_CR45","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ejheart.2003.11.006","volume":"6","author":"Sliwa","year":"2004","unstructured":"Sliwa K, Woodiwiss A, Libhaber E et al (2004) C-reactive protein predicts response to pentoxifylline in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail 6:731\u2013734","journal-title":"Eur J Heart Fail"},{"key":"1626_CR46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archsurg.133.1.94","volume":"133","author":"Staubach","year":"1998","unstructured":"Staubach KH, Schroder J, Stuber F et al (1998) Effect of pentoxifylline in severe sepsis: results of a randomized, double-blind, placebo-controlled study. Arch Surg 133:94\u2013100","journal-title":"Arch Surg"},{"key":"1626_CR47","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2567.1997.00354.x","volume":"92","author":"Trajkovic","year":"1997","unstructured":"Trajkovic V, Badovinac V, Popadic D et al (1997) Cell-specific effects of pentoxifylline on nitric oxide production and inducible nitric oxide synthase mRNA expression. Immunology 92:402\u2013406","journal-title":"Immunology"},{"key":"1626_CR48","doi-asserted-by":"crossref","first-page":"M429","DOI":"10.1097\/00002480-199609000-00025","volume":"42","author":"Tsang","year":"1996","unstructured":"Tsang GM, Allen S, Pagano D et al (1996) Pentoxifylline preloading reduces endothelial injury and permeability in cardiopulmonary bypass. ASAIO J 42:M429\u2013M434","journal-title":"ASAIO J"},{"key":"1626_CR49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1010-7940(96)80092-3","volume":"10","author":"Turkoz","year":"1996","unstructured":"Turkoz R, Yorukoglu K, Akcay A et al (1996) The effect of pentoxifylline on the lung during cardiopulmonary bypass. Eur J Cardiothorac Surg 10:339\u2013346","journal-title":"Eur J Cardiothorac Surg"},{"key":"1626_CR50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1053\/rmed.2001.1255","volume":"96","author":"Ustunsoy","year":"2002","unstructured":"Ustunsoy H, Sivrikoz MC, Bakir K et al (2002) The inhibition of pro-inflammatory cytokines with pentoxifylline in the cardiopulmunary bypass lung. Respir Med 96:275\u2013279","journal-title":"Respir Med"},{"key":"1626_CR51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1540-8191.2006.00169.x","volume":"21","author":"Ustunsoy","year":"2006","unstructured":"Ustunsoy H, Sivrikoz MC, Tarakcioglu M et al (2006) The effects of pentoxifylline on the myocardial inflammation and ischemia-reperfusion injury during cardiopulmonary bypass. J Card Surg 21:57\u201361","journal-title":"J Card Surg"},{"key":"1626_CR52","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.4049\/jimmunol.151.4.2318","volume":"151","author":"Van","year":"1993","unstructured":"Van Leenen D, Van Der Poll T, Levi M et al (1993) Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees. J Immunol 151:2318\u20132325","journal-title":"J Immunol"},{"key":"1626_CR53","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/BF01965986","volume":"36","author":"Vittone","year":"1980","unstructured":"Vittone L, Chiappe LE, Argel MI et al (1980) The mechanical and biochemical effects of pentoxifylline on the perfused rat heart. Experientia 36:1088\u20131090","journal-title":"Experientia"},{"key":"1626_CR54","first-page":"451","volume":"112","author":"Wang","year":"1992","unstructured":"Wang P, Ba ZF, Morrison MH et al (1992) Mechanism of the beneficial effects of pentoxifylline on hepatocellular function after trauma hemorrhage and resuscitation. Surgery 112:451\u2013457; discussion 457\u2013458","journal-title":"Surgery"},{"key":"1626_CR55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1074-7613(00)80423-9","volume":"6","author":"Wang","year":"1997","unstructured":"Wang W, Tam WF, Hughes CC et al (1997) c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation. Immunity 6:165\u2013174","journal-title":"Immunity"},{"key":"1626_CR56","doi-asserted-by":"crossref","first-page":"F1090","DOI":"10.1152\/ajprenal.00517.2005","volume":"291","author":"Wang","year":"2006","unstructured":"Wang W, Zolty E, Falk S et al (2006) Pentoxifylline protects against endotoxin-induced acute renal failure in mice. Am J Physiol Renal Physiol 291:F1090\u2013F1095","journal-title":"Am J Physiol Renal Physiol"},{"key":"1626_CR57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-198734010-00003","volume":"34","author":"Ward","year":"1987","unstructured":"Ward A, Clissold SP (1987) Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34:50\u201397","journal-title":"Drugs"},{"key":"1626_CR58","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1536\/ihj.23.235","volume":"23","author":"Watanabe","year":"1982","unstructured":"Watanabe H, Furukawa Y, Chiba S (1982) Cardiovascular effects of aminophylline and pentoxifylline on intact dogs and isolated dog atria. Jpn Heart J 23:235\u2013243","journal-title":"Jpn Heart J"},{"key":"1626_CR59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ana.410440109","volume":"44","author":"Weber","year":"1998","unstructured":"Weber F, Polak T, Gunther A et al (1998) Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis. Ann Neurol 44:27\u201334","journal-title":"Ann Neurol"},{"key":"1626_CR60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4269\/ajtmh.1998.58.343","volume":"58","author":"Wenisch","year":"1998","unstructured":"Wenisch C, Looareesuwan S, Wilairatana P et al (1998) Effect of pentoxifylline on cytokine patterns in the therapy of complicated Plasmodium falciparum malaria. Am J Trop Med Hyg 58:343\u2013347","journal-title":"Am J Trop Med Hyg"},{"key":"1626_CR61","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00024382-200014060-00004","volume":"14","author":"Yada-Langui","year":"2000","unstructured":"Yada-Langui MM, Coimbra R, Lancellotti C et al (2000) Hypertonic saline and pentoxifylline prevent lung injury and bacterial translocation after hemorrhagic shock. Shock 14:594\u2013598","journal-title":"Shock"},{"key":"1626_CR62","doi-asserted-by":"crossref","first-page":"H832","DOI":"10.1152\/ajpheart.00178.2005","volume":"289","author":"Zhang","year":"2005","unstructured":"Zhang M, Xu YJ, Saini HK et al (2005) Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in ischemic-reperfused heart. Am J Physiol Heart Circ Physiol 289:H832\u2013H839","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-009-1626-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-009-1626-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-009-1626-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T02:16:12Z","timestamp":1739412972000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-009-1626-9"}},"subtitle":["Bedeutung bei herzchirurgischen Eingriffen","Importance in cardiac surgery"],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["1626"],"URL":"https:\/\/doi.org\/10.1007\/s00101-009-1626-9","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"type":"print","value":"0003-2417"},{"type":"electronic","value":"1432-055X"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}